The current study involving 469 CRC patients revealed that CD166 expression was not correlated with OS of CRC patients in multivariate regression analysis (HR = 1.20, 95% CI = 0.45-3.22, P = 0.72). This evidence concerns the gene ALCAM and colorectal carcinoma.